April 28, 2025

Paternal Depression Tied to Child Behavior Study

Paternal depression was associated with 25%–37% higher behavior problem scores, researchers wrote, based on a U.S. cohort study of 1,422 children.

Conexiant

April 28, 2025

Esketamine Plus SNRI Cuts Relapse, Study

Real-world study finds esketamine combined with an SNRI linked to lower mortality, hospitalization, and relapse rates compared to esketamine plus SSRI in treatment-resistant depression.

Conexiant

April 24, 2025

FDA Warns of Topical Finasteride Risks

The FDA has issued a safety alert on compounded topical finasteride products, citing adverse events and emphasizing the lack of regulatory approval or safety evaluation.

Conexiant

April 24, 2025

Medical Oddities: Back Pain’s Cellular Villains Found?

Back pain’s got villains, green tea’s got perks, and empathy might outlast your logic this week.

Conexiant

April 23, 2025

Long-Term EEG Monitoring Now Authorized in the United States

The FDA has authorized Minder, the first implantable continuous electroencephalogram monitor, offering long-term brain activity tracking for improved epilepsy management, available in the U.S.

Conexiant

April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

April 22, 2025

Heavy Metals Found in Toothpaste

There are some "heavy metals that are essential in small quantities but could result in adverse effects if present in excess."

Conexiant

April 22, 2025

Eating Disorders Prevalent Among Male Populations

"Over 1 in 5 participants met criteria for any probable eating disorder diagnosis," reports new research that examined eating disorder prevalence among 1,553 boys and men in Canada and the U.S.

Conexiant

April 21, 2025

New Findings Show No Difference in IGE Treatment Strategies

A study found no statistically significant differences in treatment failure rates between substitution monotherapy and add-on therapy for women with idiopathic generalized epilepsy, indicating both options are viable.

Conexiant